BIOPLUS ACQUISITION CORP-A (BIOS) Stock Price, Quote, News and Overview
NASDAQ:BIOS - Nasdaq - KYG112171171 - Common Stock - Currency: USD
BIOS Quote, Performance and Key Statistics
10.795
-0.01 (-0.05%)
The current stock price of BIOS is 10.795 USD. In the past month the price increased by 0.05%. In the past year, price increased by 7.41%.
About BIOS
Company Profile
BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2021-12-03. The firm is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm intends to focus its search on companies in the life sciences industry. The firm has not commenced any operations nor generated any revenue.
Company Info
BIOPLUS ACQUISITION CORP-A
260 Madison Avenue, Suite 800
New York City NEW YORK 60015 US
CEO: Daniel E. Greenleaf
Employees: 2
Phone: 12122874092.0
BIOPLUS ACQUISITION CORP-A / BIOS FAQ
What is the stock price of BIOPLUS ACQUISITION CORP-A today?
The current stock price of BIOS is 10.795 USD. The price decreased by -0.05% in the last trading session.
What is the ticker symbol for BIOPLUS ACQUISITION CORP-A stock?
The exchange symbol of BIOPLUS ACQUISITION CORP-A is BIOS and it is listed on the Nasdaq exchange.
On which exchange is BIOS stock listed?
BIOS stock is listed on the Nasdaq exchange.
What is BIOPLUS ACQUISITION CORP-A worth?
BIOPLUS ACQUISITION CORP-A (BIOS) has a market capitalization of 209.10M USD. This makes BIOS a Micro Cap stock.
How many employees does BIOPLUS ACQUISITION CORP-A have?
BIOPLUS ACQUISITION CORP-A (BIOS) currently has 2 employees.
What are the support and resistance levels for BIOPLUS ACQUISITION CORP-A (BIOS) stock?
BIOPLUS ACQUISITION CORP-A (BIOS) has a support level at 10.75 and a resistance level at 10.81. Check the full technical report for a detailed analysis of BIOS support and resistance levels.
Should I buy BIOPLUS ACQUISITION CORP-A (BIOS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIOS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIOS, evaluating the profitability, health, valuation and growth aspects
- BIOPLUS ACQUISITION CORP-A (BIOS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOPLUS ACQUISITION CORP-A (BIOS) Sales and EPS estimates to see what analysts future expectations are.
- BIOPLUS ACQUISITION CORP-A (BIOS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOPLUS ACQUISITION CORP-A (BIOS) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOPLUS ACQUISITION CORP-A (BIOS) Stock Chart to make your own analysis
- BIOPLUS ACQUISITION CORP-A (BIOS) Latest news and press-releases to stay up to date.
Does BIOPLUS ACQUISITION CORP-A (BIOS) stock pay dividends?
BIOS does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOPLUS ACQUISITION CORP-A (BIOS)?
The PE ratio for BIOPLUS ACQUISITION CORP-A (BIOS) is 53.97. This is based on the reported non-GAAP earnings per share of 0.2 and the current share price of 10.795 USD. Check the full fundamental report for a full analysis of the valuation metrics for BIOS.
BIOS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to BIOS. When comparing the yearly performance of all stocks, BIOS turns out to be only a medium performer in the overall market: it outperformed 69.38% of all stocks.
BIOS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BIOS. BIOS has a bad profitability rating. Also its financial health evaluation is rather negative.
BIOS Financial Highlights
Over the last trailing twelve months BIOS reported a non-GAAP Earnings per Share(EPS) of 0.2. The EPS increased by 1103.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 4.18% | ||
| ROE | 4.75% | ||
| Debt/Equity | 0.04 |
BIOS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to BIOS. The Buy consensus is the average rating of analysts ratings from 3 analysts.